Related Experiment Video
Updated: Jun 20, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Comprehensive characterization of chronic midazolam exposure on neonates and long-term neurodevelopment
Nghi M Nguyen1,2,3, Pranavi Athota1, Adrian Flores1
1Department of Anesthesiology, University of Nebraska Medical Center (UNMC), Omaha, NE, USA.
Insights
Neonatal exposure to midazolam (MDZ), a common ICU sedative, can lead to long-term neurodevelopmental issues. This study shows chronic MDZ use in newborns alters physical development, brain chemistry, and behavior into adulthood.
Area of Science:
- Neonatal pharmacology
- Neurodevelopmental toxicology
- Pediatric intensive care
Background:
- Preterm birth affects 1 in 10 U.S. newborns, increasing risks for surgical interventions, mechanical ventilation, and prolonged sedation.
- Long-term sedative exposure in neonates may pose significant neurodevelopmental risks with lasting impacts.
- Midazolam (MDZ), a benzodiazepine, is frequently used for sedation in neonatal intensive care units (NICUs).
Purpose of the Study:
- To investigate the long-term effects of neonatal midazolam (MDZ) exposure on neurodevelopmental outcomes.
- To comprehensively characterize phenotypic, molecular, biochemical, and behavioral changes in neonates exposed to MDZ.
- To establish a preclinical model for understanding MDZ's impact on development across key life stages.
Main Methods:
- Utilized a preclinical rodent model to simulate chronic midazolam (MDZ) exposure in neonates.
- Conducted a comprehensive assessment of physical attributes, body weight, and eating behaviors.
- Analyzed dopamine release, pro-inflammatory cytokine levels, and growth factors in the brain.
- Evaluated anxiety-like behavior and social interaction across developmental milestones.
Main Results:
- Neonatal MDZ exposure negatively impacted early physical development and led to accelerated adult weight gain, suggesting binge eating predisposition.
- Adult MDZ-exposed rats showed significantly reduced dopamine release and elevated pro-inflammatory cytokines and growth factors in the brain.
- Heightened anxiety-like behavior and reduced social interaction were observed during early adolescence in MDZ-exposed rats.
Conclusions:
- Long-term midazolam (MDZ) exposure during the neonatal period has profound and lasting effects on physical, biochemical, and behavioral outcomes.
- Early MDZ exposure may predispose individuals to altered eating behaviors, reduced dopamine function, and neuroinflammation.
- Findings provide a foundation for understanding the mechanisms underlying neurodevelopmental complications associated with neonatal sedative use.
Abstract:
Approximately 1 in 10 U.S. newborns are born preterm (<37 weeks of gestation), facing risks of low birth weight, respiratory and birth deficits often requiring surgery, mechanical ventilation, and prolonged sedation. Such long-term exposure to sedatives in these babies can potentially pose neurodevelopmental risks and can further impact changes later in life. The present study focused on midazolam (MDZ), a benzodiazepine class drug commonly used as sedative in the neonatal intensive care unit (NICU). Using a robust preclinical rodent model mimicking chronic MDZ exposure, we did a comprehensive characterization on the phenotypic, molecular, biochemical, and behavioral outcomes in these exposed neonates across key developmental milestones. Our findings indicate that long-term MDZ exposure during the neonatal period negatively affects physical attributes in early childhood. While adult bodyweights between control and MDZ-exposed rats remain comparable, the MDZ rats exhibit accelerated and robust weight gain, potentially indicating a predisposition for binge eating behavior. Additionally, dopamine release in MDZ-exposed rats is markedly reduced in adulthood. Elevated levels of pro-inflammatory cytokines and growth factors in the brain during adulthood suggest a shift in development due to early MDZ exposure. Further, trends of heightened anxiety-like behavior and reduced social interaction during early adolescence compared to other stages were observed. Collectively, our study provides a comprehensive assessment of how long-term MDZ exposure during neonatal stages impacts outcomes throughout life, laying the foundation for understanding mechanisms that contribute to neurodevelopmental complications associated with long-term MDZ use in neonates.
More Related Videos
Related Concept Videos
Long-term Potentiation
Long-term Depression
Long-term Potentiation
Hebbian LTP
LTP can occur when presynaptic neurons...
Long-term Depression
Calcium Ion Concentration Mechanism
If over time, all...

